Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Diagnosis & Prognosis|November 6, 2024
PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With EnzalutamideToshiki Oka, Koji Hatano, Masaru Tani, et al.
Heliyon|October 9, 2023
Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinomaToshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2026
Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With EnzalutamideTomohiro Kanaki, Koji Hatano, Toshiki Oka, et al.
Anticancer Research|January 31, 2025
Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone MetastasesGaku Yamamichi, Taigo Kato, Akihiro Yoshimura, et al.
Cancer Science|November 20, 2024
Bacterial information in serum extracellular vesicles reflects the inflammation of adherent perinephric fatToshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, et al.
Anticancer Research|February 27, 2026
SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell CarcinomaYohei Okuda, Junko Murai, Tsuyoshi Takashima, et al.
BJUI Compass|May 1, 2026
Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancerMasaru Tani, Koji Hatano, Takashi Kamiya, et al.
Scientific Reports|July 6, 2026
Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinomaAkihiro Yoshimura, Taigo Kato, Yasutomo Nakai, et al.
Cancer Science|September 16, 2025
Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate CancerMasaru Tani, Koji Hatano, Yu Ishizuya, et al.
Cancer Science|December 4, 2024
Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese menSaizo Fujimoto, Koji Hatano, Eri Banno, et al.
Pageof 4